The ACO Show

Bob Kocher: Aledade's First Investor


Listen Later

Dr. Bob Kocher (@bobkocher) is a member of Aledade’s Board of Directors and a Partner at Venrock, where he focuses on healthcare IT and services investments. Additionally, he is a Consulting Professor at Stanford University School of Medicine, Senior Fellow and Advisory Board Member at the Leonard D. Schaeffer Center for Health Policy and Economics at USC, and Guest Scholar at the Brookings Institution Engleberg Center for Health Reform. Bob talks about how he went from clinical medicine to health policy to venture capital and why he was Aledade’s first investor. He even gives Josh (@DrJIsrael ) and Joe (@JoeShonkwiler) some background on his annual list of healthcare predictions.
...more
View all episodesView all episodes
Download on the App Store

The ACO ShowBy Aledade Inc

  • 4.9
  • 4.9
  • 4.9
  • 4.9
  • 4.9

4.9

101 ratings


More shows like The ACO Show

View all
TED Radio Hour by NPR

TED Radio Hour

21,968 Listeners

Planet Money by NPR

Planet Money

30,795 Listeners

Real Time with Bill Maher by HBO Podcasts

Real Time with Bill Maher

15,454 Listeners

Odd Lots by Bloomberg

Odd Lots

1,959 Listeners

The Daily by The New York Times

The Daily

112,401 Listeners

What the Health? From KFF Health News by KFF Health News

What the Health? From KFF Health News

493 Listeners

An Arm and a Leg by An Arm and a Leg

An Arm and a Leg

1,080 Listeners

Becker’s Healthcare Podcast by Becker's Healthcare

Becker’s Healthcare Podcast

198 Listeners

The Happiness Lab: Getting Unstuck by Pushkin Industries

The Happiness Lab: Getting Unstuck

14,289 Listeners

Tradeoffs by Tradeoffs

Tradeoffs

389 Listeners

The Prof G Pod with Scott Galloway by Vox Media Podcast Network

The Prof G Pod with Scott Galloway

5,561 Listeners

Hard Fork by The New York Times

Hard Fork

5,522 Listeners

Raising Health by Andreessen Horowitz, a16z Bio + Health

Raising Health

151 Listeners

Plain English with Derek Thompson by The Ringer

Plain English with Derek Thompson

2,183 Listeners

Not Otherwise Specified by NEJM Group

Not Otherwise Specified

66 Listeners